Annual Operating Expenses
$791.05 M
-$478.11 M-37.67%
01 December 2023
Summary:
Sinovac Biotech annual total operating expenses is currently $791.05 million, with the most recent change of -$478.11 million (-37.67%) on 01 December 2023. During the last 3 years, it has risen by +$563.42 million (+247.51%). SVA annual operating expenses is now -37.67% below its all-time high of $1.27 billion, reached on 31 December 2022.SVA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly total operating expenses is not available.SVA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +247.5% | - |
| 5 y5 years | +395.9% | - |
SVA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.7% | +247.5% | ||
| 5 y | 5 years | -37.7% | +446.6% | ||
| alltime | all time | -37.7% | >+9999.0% |
Sinovac Biotech Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $791.05 M(-37.7%) | - |
| Dec 2022 | $1.27 B(+69.6%) | - |
| Dec 2021 | $748.45 M(+228.8%) | - |
| Dec 2020 | $227.64 M(+57.3%) | $86.89 M(+18.1%) |
| Sept 2020 | - | $73.56 M(+63.7%) |
| June 2020 | - | $44.94 M(+102.1%) |
| Mar 2020 | - | $22.24 M(-44.4%) |
| Dec 2019 | $144.73 M(-9.3%) | $39.99 M(-0.1%) |
| Sept 2019 | - | $40.05 M(+8.6%) |
| June 2019 | - | $36.88 M(+32.7%) |
| Mar 2019 | - | $27.80 M(-39.8%) |
| Dec 2018 | $159.54 M(+46.8%) | $46.20 M(+40.4%) |
| Sept 2018 | - | $32.91 M(-35.2%) |
| June 2018 | - | $50.79 M(+71.6%) |
| Mar 2018 | - | $29.61 M(+127.7%) |
| Dec 2017 | $108.65 M(+121.5%) | - |
| Dec 2016 | $49.06 M(+8.3%) | $13.00 M(-21.9%) |
| Sept 2016 | - | $16.66 M(+46.8%) |
| June 2016 | - | $11.35 M(+41.1%) |
| Mar 2016 | - | $8.04 M(-37.6%) |
| Dec 2015 | $45.28 M(-0.5%) | $12.89 M(+2.8%) |
| Sept 2015 | - | $12.53 M(+14.3%) |
| June 2015 | - | $10.96 M(+23.0%) |
| Mar 2015 | - | $8.91 M(-29.2%) |
| Dec 2014 | $45.50 M(+10.3%) | $12.59 M(+11.8%) |
| Sept 2014 | - | $11.27 M(-6.0%) |
| June 2014 | - | $11.99 M(+24.1%) |
| Mar 2014 | - | $9.66 M(+8.3%) |
| Dec 2013 | $41.23 M(-16.0%) | $8.92 M(-23.1%) |
| Sept 2013 | - | $11.60 M(+1.4%) |
| June 2013 | - | $11.43 M(+23.4%) |
| Mar 2013 | - | $9.27 M(-33.0%) |
| Dec 2012 | $49.08 M | $13.82 M(+14.5%) |
| Sept 2012 | - | $12.07 M(+7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $11.29 M(-5.2%) |
| Mar 2012 | - | $11.90 M(+88.3%) |
| Dec 2011 | $31.89 M(+10.7%) | $6.32 M(-44.5%) |
| Sept 2011 | - | $11.39 M(+49.0%) |
| June 2011 | - | $7.65 M(+17.2%) |
| Mar 2011 | - | $6.53 M(-42.5%) |
| Dec 2010 | $28.80 M(+23.7%) | $11.34 M(+57.7%) |
| Sept 2010 | - | $7.19 M(+22.0%) |
| June 2010 | - | $5.89 M(+34.7%) |
| Mar 2010 | - | $4.37 M(-45.9%) |
| Dec 2009 | $23.28 M(+11.6%) | $8.09 M(+57.2%) |
| Sept 2009 | - | $5.14 M(-7.8%) |
| June 2009 | - | $5.58 M(+24.7%) |
| Mar 2009 | - | $4.47 M(-0.8%) |
| Dec 2008 | $20.85 M(+53.7%) | $4.51 M(-5.7%) |
| Sept 2008 | - | $4.78 M(-30.4%) |
| June 2008 | - | $6.88 M(+46.7%) |
| Mar 2008 | - | $4.69 M(+56.6%) |
| Dec 2007 | $13.56 M(+27.0%) | $2.99 M(-41.7%) |
| Sept 2007 | - | $5.13 M(+88.6%) |
| June 2007 | - | $2.72 M(+34.5%) |
| Dec 2006 | $10.68 M(-3.5%) | - |
| June 2006 | - | $2.02 M(-81.4%) |
| Dec 2005 | $11.07 M(+17.0%) | $10.89 M(>+9900.0%) |
| Sept 2005 | - | $58.90 K(-97.8%) |
| June 2005 | - | $2.73 M(+9.2%) |
| Dec 2004 | $9.46 M(+314.6%) | $2.50 M(+5.0%) |
| Sept 2004 | - | $2.38 M(+4.0%) |
| June 2004 | - | $2.29 M(+17.6%) |
| Dec 2003 | $2.28 M(+504.1%) | $1.95 M(+1375.7%) |
| Sept 2003 | - | $132.00 K |
| Apr 2002 | $377.80 K(-25.6%) | - |
| Apr 2001 | $507.50 K(+42.7%) | - |
| Apr 2000 | $355.60 K(+5370.8%) | - |
| Apr 1999 | $6500.00 | - |
FAQ
- What is Sinovac Biotech annual total operating expenses?
- What is the all time high annual operating expenses for Sinovac Biotech?
- What is the all time high quarterly operating expenses for Sinovac Biotech?
What is Sinovac Biotech annual total operating expenses?
The current annual operating expenses of SVA is $791.05 M
What is the all time high annual operating expenses for Sinovac Biotech?
Sinovac Biotech all-time high annual total operating expenses is $1.27 B
What is the all time high quarterly operating expenses for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total operating expenses is $86.89 M